| 1. |
Jorizzo JL, White WL, Zanolli MD, et al. Sclerosing panniculitis: a clinicopathologic assessment. Arch Dermatol, 1991, 127(4): 554-558.
|
| 2. |
Walsh SN, Santacruz DJ. Lipodermatosclerosis: a clinicopathological study of 25 cases. J Am Acad Dermatol, 2010, 62(6): 1005-1012.
|
| 3. |
劉影, 陳德宇. 硬化性脂膜炎的研究進展. 中國皮膚性病學雜志, 2015, 29(2): 197-199.
|
| 4. |
Miteva M, Romanelli P, Kirsner RS. Lipodermatosclerosis. Dermatol Ther, 2010, 23(4): 375-388.
|
| 5. |
Bruce AJ, Bennett DD, Lohse CM, et al. Lipodermatosclerosis: review of cases evaluated at Mayo Clinic. J Am Acad Dermatol, 2002, 46(2): 187-192.
|
| 6. |
朱學駿, 孫建方. 皮膚病理學與臨床的聯系. 北京: 北京大學醫學出版社, 2007: 372-373.
|
| 7. |
Odom RB, James WD, Berger TG. 安德魯斯臨床皮膚病學. 北京: 科學出版社, 2004: 510-511.
|
| 8. |
梁俊琴, 布瓦杰爾·亞克亞, 普雄明, 等. 硬化性脂膜炎 13 例臨床分析. 實用醫學雜志, 2014, 30(11): 1846-1847.
|
| 9. |
Carson P, Hong CJ, Otero-Vinas MA, et al. Liver enzymes and lipid levels in patients with lipodermatosclerosis and venous ulcers treated with a prototypic anabolic steroid (stanozolol): a prospective, randomized, Double-Blinded, Placebo-Controlled trial. Int J Low Extrem Wounds, 2015, 14(1): 11-18.
|